{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rockford",
      "state": "IL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "71079",
      "recalling_firm": "Mylan Institutional LLC",
      "address_1": "4901 Hiawatha Dr",
      "address_2": "N/A",
      "postal_code": "61103-1287",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1329-2015",
      "product_description": "Cytarabine Injection 100 mg/5 mL (20 mg/mL), 5 mL Single-Dose Vial (NDC 0069-0152-01), packaged in 10 x 5 mL Vials per carton (NDC 0069-0152-02), Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY  10017.",
      "product_quantity": "8,340 vials",
      "reason_for_recall": "Presence of Particulate Matter",
      "recall_initiation_date": "20150423",
      "center_classification_date": "20150813",
      "termination_date": "20160629",
      "report_date": "20150819",
      "code_info": "Lot # 7801050, Exp. Date. 05/2015"
    }
  ]
}